On The?BioCentury Inc.?Show, our CEO,?Vik Bajaj, joins?Steve Usdin?to discuss the limitations of AI in biology today and what’s needed for this technology to start creating insights that can be used to create the drugs of tomorrow. Learn more about the gap between scientific advancements and real-world healthcare delivery in Vik’s latest interview here: https://lnkd.in/gWP5TU-D
Foresite Labs
生物技术
San Francisco，California 4,976 位关注者
A center for entrepreneurial innovation at the nexus of data science and healthcare
关于我们
Foresite Labs incubates companies that will address some of our greatest unmet medical needs. We believe that the tools of AI and data science, when applied with scientific rigor, will greatly accelerate scientific discovery and the development of new products and services that benefit patients. Our work powers drug discovery and company formation, and provides the core around which new ideas are realized and incubated. We offer competitive salaries, excellent benefits, a flexible work environment, and the opportunity to learn from top thinkers in various disciplines. Foresite Labs is headquartered in San Francisco and Boston. Foresite Labs Values Truth over progression: We follow the science, pursuing ideas that are grounded in data and abandoning them when not supported by the evidence. Take good risks: Our culture values informed risk-taking: good decisions are celebrated even when they result in bad outcomes. Everyone feels safe to contribute ideas and to learn from failure. Single accountable person: The project team lead is accountable for all decisions and for maintaining transparency and information flow within the team; we trust the project teams. The Review Committee unlocks capital and sets directions. Simplicity and Focus: “Companies die from indigestion, not starvation” (Bill Hewlett) We will focus on a few ideas aggressively and minimize all other distractions. Everyone will have a few key goals that have measurable outcomes. Respect and Community: Our employees are our greatest asset; everyone invests in creating an environment of collaboration and respect. We support their careers and career development whether they stay, go to a Labs company, or end up somewhere else.
- 网站
-
https://www.foresitelabs.com
Foresite Labs的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- San Francisco，California
- 类型
- 私人持股
- 创立
- 2019
地点
Foresite Labs员工
动态
-
The identifeye HEALTH team, a Foresite Capital portfolio company, visited our offices last week to demo the company's innovative retinal scanning platform. Did you know that the eyes can reveal critical insights into overall health, often detecting early signs of diseases like diabetes? identifeye HEALTH has developed an advanced, AI-powered retinal imaging system designed for seamless integration into primary care - capturing high-quality images with ease. We loved getting hands-on experience with this technology! Left to right: Maya Venkatraman, Andrea Mich, CEO Vasiliki (Vicky) Demas and Marco M. Photo by our CEO Vik Bajaj.
-
-
Celebrating the synergy between AI and healthcare at NeurIPS 2024 with Hetu K from Xaira Therapeutics, along with Vik Bajaj, Chris Graves, and Scott McIsaac of Foresite Labs. Thank you to everyone who joined us!
-
-
Great addition to the team at our incubated company Xaira Therapeutics!
We're excited to welcome Paulo Fontoura to our team! Paulo joins us as chief medical officer. He brings a wealth of experience and deep insight to help advance our mission of leveraging AI to transform drug discovery. We're thrilled he's on board for this journey. More info in today's announcement: https://bit.ly/3BxfbfO
-
-
Congratulations to?Xaira Therapeutics?for being named to?Fortune’s 2024 50 AI Innovators list! This list recognizes companies at the forefront of artificial intelligence that are solving complex challenges across industries. Xaira harnesses AI to reimagine drug discovery, with the goal of bringing life-changing therapies to patients faster. As Xaira’s co-incubator, alongside?ARCH Venture Partners, we’re proud to see their work recognized by Fortune. Check out the full list of the top 50 AI Innovators below.
-
Congratulations to our venture partner Scott McIsaac on his appointment to the Life Sciences Research Foundation advisory board! This prestigious program identifies exceptional postdoc scientists and arranges funding from biotech and pharma companies, foundations, and philanthropic individuals for the duration of their awards. Scott is an alumnus of this program, as is David Baker, co-founder of our incubated company Xaira Therapeutics and newly minted Nobel laureate. Proud of you, Scott! We look forward to seeing what you accomplish with this impressive organization.
Welcoming Scott McIsaac to the Advisory Board of the Life Sciences Research Foundation!
-
-
Our San Francisco team learning the art of kintsugi yesterday at Stone Gold Pottery. We learned about wabi-sabi - the practice of luring beauty out of unexpected places - and the meditative joys (& frustrations, not gonna lie) of breaking and repairing pottery to reveal a new and more beautiful piece. Top place goes to Hyunsung John Kim for his beautiful work. W/ Tim Aikin, Ian Tong, MD, Ramprasad Reddy Akavaram, Selene Clay, Ashton Teng, Cindy Lundin Mesaros, Waael Zahriya
-
-
Our co-founder and CEO Vik Bajaj is at #HLTH2024 asking the question: When will AI enable new ways of delivering care that improve outcomes and reduce costs in truly dramatic and unexpected ways? Listen for his take from Las Vegas. #healthcareonLinkedIn
-
Our co-founder and CEO Vik Bajaj had a good conversation about AI's impact on drug development in the Mendelspod podcast. Thank you to host Theral Timpson. Listen at the link below.
The question everyone’s been asking: How will AI impact drug development? We ask venture capitalist Vik Bajaj about the new biotech unicorn, Xaira Therapeutics. https://lnkd.in/gh4-TJam
-
-
We're excited to share that?Mary Helen Black?has been promoted to SVP and head of human genomics at?Foresite Labs! Mary Helen has been a driver behind our efforts in building ML/AI analytics capabilities that support target discovery for our incubated companies. She also leads and contributes to multiple stealth company incubation efforts in the precision therapeutics and health care delivery space.?We're so grateful?for her work over the past two years, and excited to see what she and her team accomplish in the future!
-